SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-21-000016
Filing Date
2021-05-05
Accepted
2021-05-05 06:35:42
Documents
16
Period of Report
2021-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K isee-20210501.htm   iXBRL 8-K 38199
2 EX-99.1 isee1qearningspressrelease.htm EX-99.1 67048
8 image_01a.jpg GRAPHIC 14302
  Complete submission text file 0001410939-21-000016.txt   282857

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20210501.xsd EX-101.SCH 2442
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isee-20210501_cal.xml EX-101.CAL 727
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isee-20210501_def.xml EX-101.DEF 1665
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20210501_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20210501_pre.xml EX-101.PRE 13207
9 EXTRACTED XBRL INSTANCE DOCUMENT isee-20210501_htm.xml XML 10989
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 21891065
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences